Wall Street slammed after a steep global selloff, but was a slight uptick from the lows a positive sign for markets? The Final Round begins at 4pm EST and Yahoo Finance's Nicole Sinclair and trader Steven Guilfoyle break down all the market action.
Winners & Losers
Stocks dipping deep into the red in today's market rout were Mylan on its Meda acquisition, Twitter on disappointing user growth, and Boeing. Bloomberg reports the SEC is investigating Boeing accounting practices for two of its planes.
Stocks that bucked the rough tape include both Expedia and Tripadvisor reporting strong growth in the travel industry, and Tesla Motors. It's full speed ahead for Elon Musk and Tesla, with shares rocketing despite weak earnings, as the company projects it will deliver 80,000 to 90,000 cars this year, up from 50,000 last year.
Technicals: More pain to come?
How much more pain is in store for the markets? Yahoo Finance's Justine Underhill and BTIG chief technical strategist Katie Stockton take a closer look at the charts.
Curing cancer with immunotherapy
Vice President Joe Biden has called for a 'moonshot' to cure cancer, a mission President Obama seconded in last month's State of the Union address. And one promising area in the mission to get it done, a biotech technology known as immunotherapy. Dr. Andre Choulika, CEO and Chairman of Paris-based Cellectis, joins the Final Round to discuss the potential of immunotherapy.
Looking ahead
At 8 AM eastern we'll get government retail sales data for January. Economists are looking for a 0.3% jump in core retail sales, which backs out autos and gas.
The Fed-speak rolls on, with Dallas Fed President Rob Kaplan speaking at 9:45 AM Eastern, followed by the New York Fed's William Dudley at 10 AM.
Finally at 10 AM another read on the consumer with the University of Michigan consumer sentiment survey. The street's looking for a reading of 92.5 for February, which would be a slight uptick from January.
